Intelligent bio solutions successfully debuts intelligent fingerprinting drug screening solution at the 2023 workplace health & safety show in sydney, australia

New york, sept. 21, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful debut of its intelligent fingerprinting drug screening system at the 2023 workplace health & safety show in sydney, australia on september 20th and 21st. the non-invasive, portable system is designed to enable workplace health and safety managers to conduct simple, non-invasive workplace drug testing anytime and almost anywhere, serving as a deterrent against drug abuse and encouraging employees to adhere to health and safety policies.
INBS Ratings Summary
INBS Quant Ranking